Early Impact of Prescription Omega-3 Fatty Acids on Platelet Biomarkers in Patients with Coronary Artery Disease and Hypertriglyceridemia

Publisher： Karger

E-ISSN： 1421-9751|118|3|187-194

ISSN： 0008-6312

Source： Cardiology, Vol.118, Iss.3, 2011-06, pp. : 187-194

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Association between Omega–3 Fatty Acids and Depressive Symptoms among Patients with Established Coronary Artery Disease: Data from the Heart and Soul Study

By  

Psychotherapy and Psychosomatics, Vol. 78, Iss. 2, 2009-02 ,pp. : 125-127

Karger

Access to resources Recommend Favorite

Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: A meta-analysis of randomized controlled trials

By Zhao Yun-Tao   Chen Qiang   Sun Ya-Xun   Li Xue-Bin   Zhang Ping   Xu Yuan   Guo Ji-Hong  

Annals of Medicine, Vol. 41, Iss. 4, 2009-01 ,pp. : 301-310

Informa Healthcare

Access to resources Recommend Favorite

Omega-3 fatty acids, cognitive impairment and Alzheimer's disease

By  

Reviews in Clinical Gerontology, Vol. 20, Iss. 3, 2010-08 ,pp. : 219-238

Cambridge University Press

Access to resources Recommend Favorite

Differentiating prescription omega-3-acid ethyl esters (P-OM3) from dietary-supplement omega-3 fatty acids

By Brunton Stephen   Collins Nancy  

Current Medical Research and Opinion, Vol. 23, Iss. 5, 2007-05 ,pp. : 1139-1145

Informa Healthcare

Access to resources Recommend Favorite

Omega-3 fatty acid ethyl esters (Omacor®) for the treatment of hypertriglyceridemia

By Bhatnagar Deepak   Hussain Fatima  

Future Lipidology, Vol. 2, Iss. 3, 2007-06 ,pp. : 263-270

Future Medicine

Access to resources Recommend Favorite